HD
49
6
EL
15
3
NUE
64
-6
HPQ
55
2
CF
51
6
FLS
75
-3
NSC
65
-5
DG
8
-13
AVGO
44
4
PCAR
61
-3
DLTR
34
3
BEN
37
-3
LH
48
2
TROW
62
-2
MHK
50
-3
EA
62
2
PDCO
44
-2
PRGO
37
-3
AN
52
-5
BAC
53
-4
HD
49
6
EL
15
3
NUE
64
-6
HPQ
55
2
CF
51
6
FLS
75
-3
NSC
65
-5
DG
8
-13
AVGO
44
4
PCAR
61
-3
DLTR
34
3
BEN
37
-3
LH
48
2
TROW
62
-2
MHK
50
-3
EA
62
2
PDCO
44
-2
PRGO
37
-3
AN
52
-5
BAC
53
-4
Financhill
Back

Inovio Pharmaceuticals Quote, Financials, Valuation and Earnings

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Sell
23

INO
Inovio Pharmaceuticals

Last Price:
5.53
Seasonality Move:
10.44%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Inovio Pharmaceuticals Price Quote

$5.53
+0.01 (+-2.47%)
(Updated: November 8, 2024 at 5:17 AM ET)

Inovio Pharmaceuticals Key Stats

Sell
23
Inovio Pharmaceuticals (INO) is a Sell
Day range:
$5.48 - $5.75
52-week range:
$3.89 - $14.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.48%
Volume:
299.3K
Avg. volume:
306.4K
1-year change:
20.73%
Market cap:
$143.3M
Revenue:
$832K
EPS:
$-5.11

How Much Does Inovio Pharmaceuticals Make?

Data Unavailable

Is Inovio Pharmaceuticals Growing As A Company?

Inovio Pharmaceuticals Stock Price Performance

What Is Inovio Pharmaceuticals 52-Week High & Low?

Inovio Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Inovio Pharmaceuticals?

Is Inovio Pharmaceuticals Cash Flow Positive?

  • What Is INO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$112.4M
  • What Is Inovio Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $24.2M
  • What Is Inovio Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $69.8M

Inovio Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    INO return on invested capital is -91.32%
  • What Is Inovio Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -70.72%
  • What Is INO Return On Equity?
    ROE is a measure of profitability and is -98.72%

Inovio Pharmaceuticals Earnings Date & Stock Price

Inovio Pharmaceuticals Competitors

Inovio Pharmaceuticals Dividend Yield

Inovio Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -8.02%
Revenue: -55.41% -17.07%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 15.75
Upside from Last Price: 185.33%

Major Shareholders

  • How many INO shares are owned by institutional investors?
    12.7M INO shares are owned by institutional investors
  • How many INO shares are owned by insiders?
    4.6M INO shares are owned by insiders